Exator Tablet 5/160/20mg
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Korea Hyutex Pharmaceutical Co., Ltd.
MFDS item code 202105298 · Approved 2021.07.12
Treatment of hypertension, improvement of dyslipidemia, and prevention of cardiovascular disease (myocardial infarction, stroke, etc.)
This medication is applied to patients with essential hypertension whose blood pressure is not well controlled using a combination of amlodipine and valsartan, while atorvastatin is administered to reduce the risk of cardiovascular diseases. Atorvastatin effectively reduces the risk of myocardial infarction and stroke in patients at risk for coronary heart disease or stroke, and decreases the risk of revascularization procedures and angina. Additionally, it is used as an adjunct therapy to improve cholesterol and triglyceride levels in patients with dyslipidemia. In summary, this medication effectively improves patient health by aiding in the management of hypertension, improving cardiovascular risk factors, and treating dyslipidemia.
Take 1 tablet once daily with water. It is recommended to take this medicine at the same time each day, if possible (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. Patients taking an amlodipine/valsartan combination and atorvastatin as separate medicines may switch to this medicine (a combination tablet containing the same amounts of each active ingredient) for convenience. 5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. 5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. 10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose. Patients receiving atorvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet. The medicine may be taken at any time of day, with or without food. Dyslipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the treatment goal is to lower LDL cholesterol, LDL cholesterol is recommended for use at the start of treatment and when evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia The dose is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. If muscle problems develop or muscle enzyme levels rise significantly, this medication should be discontinued, especially for patients at risk of serious myopathy. Patients with allergies to any of the ingredients, those with specific liver or kidney diseases, pregnant or nursing women should not take this medication. Patients with insufficient sodium or body fluids may experience low blood pressure, so their condition should be carefully assessed before starting treatment and blood pressure should be monitored frequently while taking the medication. Patients with high levels of potassium in the blood or reduced kidney function should monitor their potassium levels regularly and take this medication with caution. Patients with heart failure or those who have had a myocardial infarction should closely monitor their kidney function and blood pressure while taking this medication, and extreme caution is advised in cases of severe heart disease. This medication may affect liver function, so patients with a history of liver disease should undergo regular liver function tests, and should consult a physician immediately if any abnormal symptoms occur. When driving or operating machinery, caution is advised as dizziness or fatigue may occur. This medication may interact with other drugs, so if other medications are being taken, you must inform your doctor or pharmacist, especially caution is needed when combined with certain antibiotics, antifungals, and antivirals. If symptoms such as muscle pain, weakness, or fever occur during the use of this medication, inform healthcare professionals immediately, and muscle enzyme testing may be required to evaluate the situation. Women who are pregnant or planning to become pregnant should consult healthcare providers before taking this medication, and women of childbearing age should use appropriate contraception. Nursing mothers should avoid taking this medication, and it is recommended to stop breastfeeding while taking it.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to maintain the storage temperature between 1 to 30 degrees Celsius to keep the medication safe and effective for a long time.
Light pink oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Korea Hyutex Pharmaceutical Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Dongu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.